Total Payments
$227,227
2024 Payments
$50,326
Companies
38
Transactions
562
Medicare Patients
8,154
Medicare Billing
$992,247
Payment Breakdown by Category
Other$167,894 (73.9%)
Food & Beverage$21,310 (9.4%)
Consulting$21,180 (9.3%)
Travel$16,843 (7.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $164,994 | 62 | 72.6% |
| Food and Beverage | $21,310 | 433 | 9.4% |
| Consulting Fee | $21,180 | 9 | 9.3% |
| Travel and Lodging | $16,843 | 56 | 7.4% |
| Honoraria | $2,900 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $87,152 | 138 | $0 (2024) |
| Optinose US, Inc. | $35,153 | 101 | $0 (2024) |
| GENZYME CORPORATION | $33,039 | 71 | $0 (2024) |
| GlaxoSmithKline, LLC. | $27,091 | 62 | $0 (2024) |
| AERIN MEDICAL INC. | $18,233 | 49 | $0 (2024) |
| Intersect ENT, Inc. | $12,937 | 27 | $0 (2021) |
| Genentech USA, Inc. | $5,576 | 6 | $0 (2020) |
| Medtronic, Inc. | $4,107 | 7 | $0 (2024) |
| Stryker Corporation | $636.17 | 10 | $0 (2023) |
| Spirox Inc | $371.09 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50,326 | 108 | GENZYME CORPORATION ($16,308) |
| 2023 | $52,343 | 134 | Regeneron Healthcare Solutions, Inc. ($32,580) |
| 2022 | $56,694 | 134 | Regeneron Healthcare Solutions, Inc. ($31,168) |
| 2021 | $25,908 | 46 | GlaxoSmithKline, LLC. ($10,597) |
| 2020 | $24,104 | 45 | GENZYME CORPORATION ($6,111) |
| 2019 | $7,841 | 44 | OptiNose US, Inc. ($5,858) |
| 2018 | $8,035 | 30 | Intersect ENT, Inc. ($7,525) |
| 2017 | $1,977 | 21 | Intersect ENT, Inc. ($1,063) |
All Payment Transactions
562 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/19/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/11/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: EAR NOSE & THROAT | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/27/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: Immunology | ||||||
| 11/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $1,739.93 | General |
| 11/14/2024 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $27.80 | General |
| 11/11/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,586.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $118.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/29/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: Immunology | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $79.30 | General |
| 09/24/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,238.00 | General |
| Category: Immunology | ||||||
| 09/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $749.37 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 2,448 | 2,920 | $984,716 | $301,818 |
| 2022 | 10 | 2,213 | 2,661 | $901,490 | $280,055 |
| 2021 | 11 | 1,936 | 2,292 | $662,404 | $241,514 |
| 2020 | 9 | 1,557 | 1,860 | $444,658 | $168,860 |
Total Patients
8,154
Total Services
9,733
Medicare Billing
$992,247
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 436 | 575 | $440,450 | $101,406 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 610 | 827 | $179,459 | $67,409 | 37.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 348 | 348 | $69,600 | $35,441 | 50.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 247 | 286 | $64,350 | $33,805 | 52.5% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 171 | 194 | $56,260 | $23,859 | 42.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $32,400 | $13,501 | 41.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 278 | 329 | $91,204 | $11,931 | 13.1% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 192 | 192 | $20,928 | $8,485 | 40.5% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 46 | 48 | $24,000 | $4,093 | 17.1% |
| 92511 | Exam of the nose and throat using an endoscope | Office | 2023 | 16 | 16 | $5,120 | $1,668 | 32.6% |
| 92567 | Test to assess middle ear function | Office | 2023 | 14 | 15 | $945.00 | $220.34 | 23.3% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 402 | 537 | $411,342 | $98,413 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 544 | 772 | $167,524 | $63,834 | 38.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 299 | 299 | $59,800 | $30,689 | 51.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 237 | $53,325 | $26,819 | 50.3% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 152 | 170 | $49,300 | $21,007 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 97 | 97 | $34,920 | $14,789 | 42.4% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 242 | 282 | $77,010 | $10,528 | 13.7% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 197 | 201 | $21,909 | $8,817 | 40.2% |
| 70486 | Ct scan of face without contrast | Office | 2022 | 49 | 50 | $25,000 | $4,519 | 18.1% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2022 | 15 | 16 | $1,360 | $638.78 | 47.0% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 290 | 386 | $254,665 | $77,096 | 30.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 414 | 570 | $108,080 | $47,497 | 43.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 274 | 317 | $71,325 | $37,382 | 52.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 261 | 261 | $52,200 | $26,474 | 50.7% |
About Dr. Moshe Ephrat, MD
Dr. Moshe Ephrat, MD is a Facial Plastic Surgery healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134109879.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Moshe Ephrat, MD has received a total of $227,227 in payments from pharmaceutical and medical device companies, with $50,326 received in 2024. These payments were reported across 562 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($164,994).
As a Medicare-enrolled provider, Ephrat has provided services to 8,154 Medicare beneficiaries, totaling 9,733 services with total Medicare billing of $992,247. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Facial Plastic Surgery
- Other Specialties Otolaryngology
- Location New Hyde Park, NY
- Active Since 01/19/2006
- Last Updated 07/22/2025
- Taxonomy Code 207YS0123X
- Entity Type Individual
- NPI Number 1134109879
Products in Payments
- DUPIXENT (Biological) $92,450
- Xhance (Drug) $35,153
- NUCALA (Biological) $26,873
- VIVAER STYLUS (Device) $12,345
- No Product (Device) $6,728
- PROPEL (Device) $5,867
- Xolair (Biological) $5,576
- VivAer (Device) $4,118
- Vivaer RF Stylus (Device) $1,107
- Latera (Device) $371.09
- NEUROMARK Device (Device) $346.95
- XprESS Multi-Sinus Dilation System (Device) $251.98
- INSPIRE (Device) $247.37
- Ryaltris (Drug) $241.58
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $231.07
- AYVAKIT (Drug) $194.99
- MiniCAT (Device) $161.87
- FIAGON NAVIGATION UNIT (Device) $155.89
- ACCLARENT Balloon Inflation Device (Device) $124.23
- Otovel (Drug) $120.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.